Workflow
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
Dyne TherapeuticsDyne Therapeutics(US:DYN) GlobeNewswire News Room·2025-06-18 14:25

On this news, Dyne's stock price fell $2.96 per share, or 21.42%, to close at $10.86 per share on June 17, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz conti ...